Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody

Catalog No. ABIN7538074

This anti-FCGRT (Rozanolixizumab Biosimilar) antibody is a Humanized Chimeric antibody detecting FCGRT (Rozanolixizumab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody (ABIN7538074)

Target: FCGRT (Rozanolixizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This FCGRT (Rozanolixizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-FCGRT (Rozanolixizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for FCGRT (Rozanolixizumab Biosimilar)

Target: FCGRT (Rozanolixizumab Biosimilar)

Target Type: Biosimilar

Background: Rozanolixizumab, a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases.

CAS-No: 1584645-37-3